BR0314848A - Métodos de precipitação de cristais - Google Patents
Métodos de precipitação de cristaisInfo
- Publication number
- BR0314848A BR0314848A BR0314848-3A BR0314848A BR0314848A BR 0314848 A BR0314848 A BR 0314848A BR 0314848 A BR0314848 A BR 0314848A BR 0314848 A BR0314848 A BR 0314848A
- Authority
- BR
- Brazil
- Prior art keywords
- water
- hydrated
- crystals
- allowed
- separate
- Prior art date
Links
- 239000013078 crystal Substances 0.000 title abstract 6
- 238000000034 method Methods 0.000 title abstract 2
- 238000001556 precipitation Methods 0.000 title abstract 2
- AHOUBRCZNHFOSL-UHFFFAOYSA-N 3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine Chemical compound C1=CC(F)=CC=C1C1C(COC=2C=C3OCOC3=CC=2)CNCC1 AHOUBRCZNHFOSL-UHFFFAOYSA-N 0.000 abstract 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 7
- 229960005183 paroxetine hydrochloride Drugs 0.000 abstract 4
- 239000003495 polar organic solvent Substances 0.000 abstract 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 abstract 2
- AHOUBRCZNHFOSL-YOEHRIQHSA-N (+)-Casbol Chemical compound C1=CC(F)=CC=C1[C@H]1[C@H](COC=2C=C3OCOC3=CC=2)CNCC1 AHOUBRCZNHFOSL-YOEHRIQHSA-N 0.000 abstract 1
- 229910000041 hydrogen chloride Inorganic materials 0.000 abstract 1
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 abstract 1
- 229960002296 paroxetine Drugs 0.000 abstract 1
- 238000000926 separation method Methods 0.000 abstract 1
- 239000000725 suspension Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
- C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
- C07D263/58—Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
"MéTODOS DE PRECIPITAçãO DE CRISTAIS". A presente invenção refere-se à separação de cristais de cloridrato de paroxetina 1/2 - hidratada, mediante adição de água a uma solução ou suspensão que compreende cloridrato de paroxetina e um solvente orgânico polar, o qual é isento de água ou contém no máximo 60% em peso de água, de modo a ajustar o teor de água para pelo menos 70% em peso, quando os cristais de cloridrato de paroxetina 1/2 - hidratada são deixados separar em um solvente orgânico polar contendo água. Os cristais de cloridrato de paroxetina 1/2 - hidratada não-coloridos de rosa podem ser deixados separar na presença de cloreto de hidrogênio, quando os cristais de cloridrato de paroxetina 1/2 - hidratada são deixados separar em água ou em um solvente orgânico polar contendo água.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2002273901 | 2002-09-19 | ||
| PCT/JP2003/011805 WO2004026860A1 (ja) | 2002-09-19 | 2003-09-17 | 結晶析出方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR0314848A true BR0314848A (pt) | 2005-08-02 |
Family
ID=32024971
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR0314848-3A BR0314848A (pt) | 2002-09-19 | 2003-09-17 | Métodos de precipitação de cristais |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US7329318B2 (pt) |
| EP (1) | EP1555262A4 (pt) |
| JP (1) | JP4394004B2 (pt) |
| AU (1) | AU2003271055B2 (pt) |
| BR (1) | BR0314848A (pt) |
| CA (1) | CA2496726A1 (pt) |
| WO (1) | WO2004026860A1 (pt) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050053898A1 (en) * | 2003-09-09 | 2005-03-10 | The Procter & Gamble Company | Illuminated electric toothbrushes and methods of use |
| US20050053895A1 (en) * | 2003-09-09 | 2005-03-10 | The Procter & Gamble Company Attention: Chief Patent Counsel | Illuminated electric toothbrushes emitting high luminous intensity toothbrush |
| US20050050659A1 (en) | 2003-09-09 | 2005-03-10 | The Procter & Gamble Company | Electric toothbrush comprising an electrically powered element |
| US20050066459A1 (en) * | 2003-09-09 | 2005-03-31 | The Procter & Gamble Company | Electric toothbrushes and replaceable components |
| EP1726591B1 (en) * | 2005-05-26 | 2008-09-10 | Apotecnia , S.A. | Process for manufacturing paroxetine hydrochloride hemihydrate |
| JP2010260826A (ja) * | 2009-05-08 | 2010-11-18 | Sumitomo Chemical Co Ltd | パロキセチン塩酸塩半水和物の製造方法 |
| GB201108345D0 (en) * | 2011-05-18 | 2011-06-29 | Aesica Pharmaceuticals Ltd | Process |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0223403B1 (en) * | 1985-10-25 | 1993-08-04 | Beecham Group Plc | Piperidine derivative, its preparation, and its use as medicament |
| EP1384711A1 (en) * | 1996-06-13 | 2004-01-28 | SUMIKA FINE CHEMICALS Co., Ltd. | Optical resolution of a piperidine derivative |
| GB9826180D0 (en) * | 1998-11-30 | 1999-01-20 | Smithkline Beecham Plc | Novel process |
| WO2002017921A2 (en) | 2000-08-28 | 2002-03-07 | Synthon B.V. | Paroxetine compositions and processes for making the same |
| IL159280A0 (en) * | 2001-06-14 | 2004-06-01 | Teva Pharma | A process for preparing paroxetine hcl which limits formation of pink colored compounds |
-
2003
- 2003-09-17 BR BR0314848-3A patent/BR0314848A/pt not_active IP Right Cessation
- 2003-09-17 US US10/527,317 patent/US7329318B2/en not_active Expired - Fee Related
- 2003-09-17 AU AU2003271055A patent/AU2003271055B2/en not_active Ceased
- 2003-09-17 JP JP2004537574A patent/JP4394004B2/ja not_active Expired - Fee Related
- 2003-09-17 EP EP03751270A patent/EP1555262A4/en not_active Withdrawn
- 2003-09-17 CA CA002496726A patent/CA2496726A1/en not_active Abandoned
- 2003-09-17 WO PCT/JP2003/011805 patent/WO2004026860A1/ja not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2004026860A1 (ja) | 2004-04-01 |
| AU2003271055A1 (en) | 2004-04-08 |
| JPWO2004026860A1 (ja) | 2006-01-12 |
| US20060048696A1 (en) | 2006-03-09 |
| AU2003271055B2 (en) | 2009-03-12 |
| JP4394004B2 (ja) | 2010-01-06 |
| CA2496726A1 (en) | 2004-04-01 |
| EP1555262A1 (en) | 2005-07-20 |
| EP1555262A4 (en) | 2008-04-16 |
| US7329318B2 (en) | 2008-02-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9914036A (pt) | Agentes antiincrustação | |
| SG182004A1 (en) | 1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia | |
| BR0208081A (pt) | Dispersões de matéria sintética aquosas, processo para produção das mesmas e uso das mesmas | |
| BR9814990A (pt) | Coadjuvantes de cimentação | |
| BRPI0402504A (pt) | Pneumático que tem um componente que contém óleo baixo pca | |
| BRPI0409417A (pt) | método para usar um composto, composto, e, composição | |
| BRPI0518674A2 (pt) | regime de dosagem de um agonista de receptor s1p | |
| NO20061543L (no) | Modulators of ATPBinding Cassette Transportm | |
| CY1111471T1 (el) | Μεθοδοι για τον καθαρισμο trans-(-)-δ9-τετραϋδροκανναβινολης και trans-(+)-δ9 τετραϋδροκανναβινολης | |
| BR0314848A (pt) | Métodos de precipitação de cristais | |
| BR9907309A (pt) | FluorelastÈmeros curáveis, seu uso e processo para a obtenção dos mesmos | |
| BRPI0409099A (pt) | composição de extração com solvente, e, processo para a extração de um metal a partir de solução | |
| BR0208992A (pt) | Processo para a preparação de indenos 1,3-substituìdos e compostos azapolicìclicos fundidos com arila | |
| BRPI0408707A (pt) | métodos e aparelhos para a comunicação e estabilização de partìculas pequenas | |
| BR0109602A (pt) | Glóbulos de liberação controlada contendo estavudina | |
| BRPI0605387A (pt) | processo para purificação fina de correntes que contêm 1-buteno | |
| BRPI0409739A (pt) | composto, composição farmacêutica, uso de composto, e, método para o tratamento de uma doença ou de um distúrbio | |
| BR0204286A (pt) | Cura de placas positivas | |
| BR0100803A (pt) | Processo para a preparação de organossililalquilpolissulfanos | |
| BR9611232A (pt) | Antioxidantes contendo grupos fenol e grupos de anima aromática | |
| BR0101492A (pt) | Misturas de pelo menos um enchedor e compostosde organossilìcio, processo para sua preparação eseu uso | |
| BRPI0415687B1 (pt) | Composições e processo para estabilização de cloreto de polivinila contra degradação térmica, e uso de um antioxidante fenólico estericamente impedido juntamente com um tioéter-ester | |
| BR112018077147A2 (pt) | processo de tratamento de minério de magnetita, e composição coletora | |
| BR0007562A (pt) | Componente eletrônico e utilização de uma estrutura de proteção nele contida | |
| BR0012478A (pt) | Derivados de aminotiazóis, sua preparação e composição farmacêuticas contendo os mesmos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 8A ANUIDADE(S). |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2143 DE 31/01/2012. |